Tuesday, August 5, 2008 - 07:42 in Health & Medicine
The subpoena of Johnson & Johnson broadens an investigation that has touched its competitors Abbott Laboratories and Boston Scientific.
- Biosensors DES demonstrates equivalent safety and efficacy to industry leading DESTue, 2 Sep 2008, 14:07:49 EDT
- Data on investigational drug TMC207 for MDR-TB published in New England Journal of MedicineWed, 3 Jun 2009, 17:43:51 EDT
- Thus the bile does not overflowMon, 11 May 2009, 10:51:38 EDT
- New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive productsMon, 6 Apr 2009, 9:50:36 EDT
- Novel gene mutations associated with bile duct cancer Wed, 18 Jan 2012, 17:39:22 EST